Investigating the role of EZH2 as a therapeutic target in clear cell renal cell carcinoma (ccRCC)

被引：0
|
作者：
Wei, Darmood
Ricketts, Christopher J.
Schmidt, Laura S.
Yang, Youfeng
Vocke, Cathy D.
Linehan, William M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4707
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Christie, Alana
    Xie, Xian-Jin
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2016, 96 : 230A - 230A
  • [2] EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Christie, Alana
    Xie, Xian-Jin
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2016, 29 : 230A - 230A
  • [3] Using tumor spheroids to evaluate the efficacy of EZH2 inhibitors in clear cell renal cell carcinoma (ccRCC)
    Wei, Darmood
    Yang, Youfeng
    Ricketts, Christopher J.
    Sourbier, Carole
    Schmidt, Laura S.
    Linehan, William M.
    CANCER RESEARCH, 2017, 77
  • [4] EZH2, a potential therapeutic target in Merkel cell carcinoma
    Durand, M.
    Mouchard, A.
    Esnault, C.
    Samimi, M.
    Kervarrec, T.
    Touze, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S191 - S191
  • [5] Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models
    Adelaiye-Ogala, Remi M.
    Chintala, Sreenivasulu
    Shen, Li
    Orillion, Ashley
    Ciamporcero, Eric
    Elbanna, May
    Miles, Kiersten Marie
    Gillard, Bryan
    Buck, Michael
    Pili, Roberto
    CANCER RESEARCH, 2015, 75
  • [6] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [7] EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
    Xu, Z. Q.
    Zhang, L.
    Gao, B. S.
    Wan, Y. G.
    Zhang, X. H.
    Chen, B.
    Wang, Y. T.
    Sun, N.
    Fu, Y. W.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (01): : 41 - 49
  • [8] EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
    Z. Q. Xu
    L. Zhang
    B. S. Gao
    Y. G. Wan
    X. H. Zhang
    B. Chen
    Y. T. Wang
    N. Sun
    Y. W. Fu
    Clinical and Translational Oncology, 2015, 17 : 41 - 49
  • [9] MiR-138 Induces Renal Carcinoma Cell Senescence by Targeting EZH2 and Is Downregulated in Human Clear Cell Renal Cell Carcinoma
    Liang, Jiaqian
    Zhang, Yajing
    Jiang, Guosong
    Liu, Zhouqiang
    Xiang, Wei
    Chen, Xuanyu
    Chen, Zhaohui
    Zhao, Jun
    ONCOLOGY RESEARCH, 2013, 21 (02) : 83 - 91
  • [10] The lipid metabolome of clear cell renal cell carcinoma (CCRCC).
    George, Saby
    Choi, Kyoung-Soo
    Pili, Roberto
    Kazim, Abdul Latif
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345